脂肪因子ZAG血清水平预测血液透析患者死亡
本研究在252例维持性血液透析患者的前瞻性队列中,检测基线血清ZAG水平,随访平均954天。结果显示,血清ZAG浓度与全因死亡和心血管事件显著相关,且经多因素调整后仍为独立预测因子。
要点
- 血清ZAG水平与透析患者全因死亡和心血管事件独立相关。
- ZAG与蛋白质能量消耗(PEW)在本队列中无显著关联。
- ZAG可能作为透析患者预后评估的新型生物标志物。
核心结论
- 血清ZAG是终末期肾病透析患者死亡和心血管事件的强独立预测因子。
研究设计与样本
- 前瞻性队列研究,纳入252例维持性血液透析患者,基线检测血清ZAG,随访平均954天。
主要发现
- 随访期间49例死亡,62例发生心血管事件。
- 血清ZAG与白蛋白、肌酐、甘油三酯呈负相关,与年龄呈正相关。
- Kaplan-Meier分析显示血清ZAG浓度与全因死亡和心血管事件显著相关。
- 多因素Cox回归调整人口学、代谢及心血管危险因素后,ZAG仍与全因死亡和心血管事件显著相关。
临床怎么用
- 可考虑检测透析患者血清ZAG水平以辅助风险分层,但需进一步研究确认。
局限性
- 需进一步研究确认关联并阐明机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Wasting has been associated with increased cardiovascular and all-cause mortality in chronic kidney disease (CKD). We investigated whether serum zinc-alpha2-glycoprotein (ZAG), a potent cachectic and lipid-mobilizing factor that is increased in patients with CKD, predicts clinical outcomes in patients on chronic hemodialysis. We quantified serum ZAG at baseline in a prospective cohort of 252 patients undergoing maintenance hemodialysis. Serum ZAG concentrations were inversely associated with serum albumin, creatinine, and triglycerides and, conversely, positively associated with age. Although ZAG is strongly linked to protein energy wasting (PEW) in patients with cancer, higher ZAG concentrations were not associated with PEW in our cohort. During a mean study follow-up of 954 days, 49 patients died and 62 patients experienced a cardiovascular event. Kaplan-Meier analysis revealed a significant correlation between serum ZAG concentrations and all-cause mortality and cardiovascular events. In separate multivariable Cox regression models, serum ZAG concentrations remained significantly associated with all-cause mortality and cardiovascular events after adjustment for demographic factors (age, sex, and dialysis vintage), metabolic parameters (serum albumin, prealbumin, triglycerides, cholesterol, normalized protein catabolic rate, and body mass index), and cardiovascular risk factors (diabetes, dyslipidemia, history of cardiovascular disease, smoking, and diuretic use as a proxy of residual renal function). Thus, serum ZAG appears to be a strong and independent predictor of mortality and cardiovascular events in patients with end-stage renal disease. Further studies are necessary to confirm this association and to elucidate the underlying mechanisms.
引用
- Bouchara A, Yi D, Pastural M, et al. Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients. Kidney Int. 2018. PMID: 30348306. doi:10.1016/j.kint.2018.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。